KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds affiliated with KKR & Co.
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read ...
Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to ...
Henry Schein announces strategic investment by KKR, board changes, and provides preliminary unaudited financial results and 2025 financial guidance.
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback